Protein & Cell · 2016 · 104 citations · 26 references
MedicineImmunologyOncologyImmunoregulationMolecular OncologyTumor ProgressionColorectal CancerCytokine BiologyCytokine SignalingGastrointestinal InflammationMyeloid-derived Suppressor CellsNeutrophil BiologyColitis-associated Colorectal CancerG-csf TherapyImmune Suppression MechanismsMyeloid-derived Suppressor Cell FunctionMyeloid-derived Suppressor Cell ModulationMyeloid-derived Suppressor Cell-mediated SuppressionNeoplastic ProgressionTherapeutic Target Identification
Granulocyte colony-stimulating factor (G-CSF) is an essential regulator of neutrophil trafficking and is highly expressed in multiple tumors. Myeloid derived suppressor cells (MDSCs) promote neoplastic progression through multiple mechanisms by immune suppression. Despite the findings of G-CSF function in colon cancer progression, the precise mechanism of G-CSF on MDSCs regulation and its blockade effects on tumor growth remains a worthy area of investigation. In this study we observed an overexpression of G-CSF in a mouse colitis-associated cancer (CAC) model, which was consistent with the accumulation of MDSCs in mouse colon tissues. Further in vitro studies demonstrated that G-CSF could promote MDSCs survival and activation through signal transducer and activator of transcription 3 (STAT3) signaling pathway. Moreover, compared with isotype control, anti-G-CSF mAb treatment demonstrated reduced MDSC accumulation, which led to a marked decrease in neoplasm size and number in mice. Our results indicated that G-CSF is a critical regulating molecule in the migration, proliferation and function maintenance of MDSCs, which could be a potential therapeutic target for colitis-associated cancer.
26
The Genomic Landscapes of Human Breast and Colorectal Cancers
Laura D. Wood, D. Williams Parsons, Siân Jones et al. · Science · 2007 · 2.8K citations
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Je‐In Youn, Srinivas Nagaraj, Michelle Collazo et al. · The Journal of Immunology · 2008 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +16
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Sergei I. Grivennikov, Kepeng Wang, Daniel Mucida et al. · Nature · 2012 · 1.3K citations · Full text
Medicine, Immunology, Oncology +12